In this study, we analyzed ADAM10 variants in AD cases in relation to ADAM10 protein levels in CSF to test the hypothesis that certain rare variants could be associated with the age-related downregulation of α-secretase. This evidence concerns the gene ADAM10 and Alzheimer disease.